SCHEMBL13420239

SCHEMBL13420239

COc1[nH]c(=O)[nH]c(=O)c1N=Nc1c(OC)[nH]c(=O)[nH]c1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KA3 P51812 1/20 0.37
ALDH1A1 P00352 7/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 2/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 4/20 0.36
NPC1 O15118 2/20 0.36
GDA Q9Y2T3 1/20 0.34
MAPT P10636 9/20 0.34
MEN1 O00255 7/20 0.34
KMT2A Q03164 7/20 0.34
CTDSP1 Q9GZU7 1/20 0.33
TP53 P04637 1/20 0.33
LMNA P02545 2/20 0.32
GAA P10253 3/20 0.32
POLB P06746 2/20 0.32
HTT P42858 2/20 0.32
GLA P06280 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
TYMP P19971 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8408224 0.65 RPS6KA3 (0.69) RPS6KA3ALDH1A1SMN1; SMN2KDM4ERAB9A
SCHEMBL21941231 0.65 RPS6KA3 (0.69) RPS6KA3ALDH1A1SMN1; SMN2KDM4ERAB9A
SCHEMBL22766816 0.58
SCHEMBL31243823 0.55 CTDSP1 (0.36) ALDH1A1SMN1; SMN2KDM4EHPGDCTDSP1
Uric Acid SCHEMBL3417988 0.52 GDA (1.00) ALDH1A1KDM4EHPGDGDAMAPT
Uric Acid SCHEMBL1331321 0.52 GDA (1.00) ALDH1A1KDM4EHPGDGDAMAPT
Uric Acid SCHEMBL22069923 0.52 GDA (1.00) ALDH1A1KDM4EHPGDGDAMAPT
Uric Acid SCHEMBL30062557 0.52 GDA (1.00) ALDH1A1KDM4EHPGDGDAMAPT
SCHEMBL9008314 0.52 GDA (0.71) ALDH1A1KDM4EHPGDGDAMAPT
SCHEMBL9062085 0.52 IDH1 (0.44) ALDH1A1KDM4EHPGDRAB9AGDA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7682444-B2 Process for preparing pigments LANXESS DEUTSCHLAND GMBH (DE) 2010-03-23 US disclosed
US-20080057417-A1 Process for preparing pigments LANXESS DEUTSCHLAND GMBH (DE) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080057417-A1 Process for preparing pigments MEN1, MON2, TYR RPS6KA3 4719/4885ALDH1A1 2637/4885SMN1; SMN2 1004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.